Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

W.R. Berkley Profit Rises Despite Higher Catastrophe Losses, Driven by Underwriting and Investment Gains

by Team Lumida
July 22, 2025
in Equities
Reading Time: 3 mins read
A A
0
W.R. Berkley Profit Rises Despite Higher Catastrophe Losses, Driven by Underwriting and Investment Gains
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  1. Profit Growth: W.R. Berkley’s Q2 net profit rose to $401.3 million $1/share)* from$371.9 million $0.92/share) a year ago, though it missed analyst expectations.
  2. Revenue Beat: Total revenue increased 11% to$3.67 billion, topping Wall Street forecasts, with gross and net premiums written both up over 7%.
  3. Catastrophe Losses Still Rising: Catastrophe losses climbed 11% to$99.2 million, reflecting ongoing industry-wide challenges from wildfires, wind, and flooding.
  4. Operating Income Up, ROE Down: Operating income rose to $420.5 million, but operating return on equity slipped to 20% from 22% last year.
  5. Industry Context: The results highlight Berkley’s ability to grow profit and revenue despite above-average catastrophe losses, thanks to higher underwriting gains and improved investment income.

What Happened?

W.R. Berkley reported higher Q2 profit and revenue, driven by strong underwriting and investment results, even as catastrophe losses continued to rise. The company’s profit missed analyst estimates, but premium growth and investment income offset the impact of higher claims from natural disasters.


Why It Matters?

Berkley’s results underscore the resilience of well-managed insurers in a challenging environment marked by frequent and severe catastrophe events. The ability to grow premiums and investment returns is helping offset rising claims, but persistent catastrophe losses remain a key risk for the sector.


What’s Next?

Investors will watch for trends in catastrophe losses and whether Berkley can sustain underwriting and investment gains. The broader insurance industry remains under pressure from climate-driven events, making risk management and pricing discipline critical.

Source
Previous Post

SoftBank and OpenAI’s $500 Billion Stargate AI Project Stalls, Scales Back Ambitions

Next Post

NXP Semiconductors Guides for Further Revenue Decline as Q2 Profit Drops

Recommended For You

McDonald’s Asks Franchisees for $1.2 Million a Store for Upgrades That Save $100,000 a Year

by Team Lumida
1 hour ago
McDonald’s Asks Franchisees for $1.2 Million a Store for Upgrades That Save $100,000 a Year

That is roughly 8% on capital against the 20% returns operators expect, and the company has not quantified the sales lift meant to close the gap.

Read more

Chinese Importers Negotiate Long-Term US LNG Contracts Despite Beijing Tariffs, After Hormuz Cut Off Qatari Supply

by Team Lumida
3 hours ago
Chinese Importers Negotiate Long-Term US LNG Contracts Despite Beijing Tariffs, After Hormuz Cut Off Qatari Supply

Nearly 30% of China's LNG came from Qatar last year. Energy security is now overriding trade policy.

Read more

Ford Falls 30% From Its May Peak While Analysts Raise Targets 16%, and Its Last Sell Rating Vanished Only Because an Analyst Left

by Team Lumida
4 hours ago
Ford Falls 30% From Its May Peak While Analysts Raise Targets 16%, and Its Last Sell Rating Vanished Only Because an Analyst Left

None of 23 analysts recommends selling, but the absence of bearish ratings is partly a staffing artefact rather than a judgement.

Read more

RedBird Puts $4 Billion More Into the $110 Billion Paramount-Warner Deal, Taking Its Stake to $6 Billion

by Team Lumida
4 hours ago
RedBird Puts $4 Billion More Into the $110 Billion Paramount-Warner Deal, Taking Its Stake to $6 Billion

Warner Bros. Discovery closed unchanged on completion day, which tells you the market regarded the outcome as settled long ago.

Read more

Moonshot Aims for Hong Kong — $50 Billion Valuation Locks In as China’s AI Darling Plans Early 2027 IPO With $5 Billion Raise

by Team Lumida
8 hours ago
Moonshot Aims for Hong Kong — $50 Billion Valuation Locks In as China’s AI Darling Plans Early 2027 IPO With $5 Billion Raise

Moonshot closed final private round $50B valuation. Early 2027 Hong Kong IPO Q1 planned. Raising up to $5B IPO. Kimi K3 model (July launch, competitive with OpenAI/Anthropic). ARR...

Read more

Tokenized Cash Breaks Into Mainstream — Spiko Raises $90 Million to Build on Blockchain What BlackRock Still Dominates in Traditional Finance

by Team Lumida
8 hours ago
Tokenized Cash Breaks Into Mainstream — Spiko Raises $90 Million to Build on Blockchain What BlackRock Still Dominates in Traditional Finance

Spiko $90M Series B round, $800M valuation (NEA-led). London/Paris fintech. Tokenized euro money-market funds. $2.7B AUM across products. Flagship Spiko Amundi Overnight Swap $1.5B (vs BlackRock USD Institutional...

Read more

China’s AI Insurgent Raises $12 Billion — DeepSeek Crushes Fundraising Target as V4 Flash Resets Cost-Performance Equation Against OpenAI and Anthropic

by Team Lumida
8 hours ago
Chinese AI Models Generate Only 10% of OpenAI/Anthropic Revenue; Valuation Multiples Appear ‘Exorbitant’ for DeepSeek, Moonshot

DeepSeek raising 80B+ yuan ($12B minimum), target 50B exceeded. Could reach 100B yuan. CATL + Tencent largest backers. Early 2027 IPO planned. V4 Flash model success (cost-performance breakthrough)....

Read more

KKR Pivots to the Back Office — $5 Billion Gen II Bet Signals Shift From Deal-Making to Steady Fee Income as Private Capital Explodes

by Team Lumida
10 hours ago
KKR Pivots to the Back Office — $5 Billion Gen II Bet Signals Shift From Deal-Making to Steady Fee Income as Private Capital Explodes

KKR acquiring fund administrator Gen II for ~$5B (including debt). Gen II: 12,000+ entities (PE, private credit, infrastructure, real estate). Tax/compliance/back-office services. Sellers: Hg Capital + General Atlantic...

Read more

Prudential Moves $5 Billion to Prismic, Where More Than $22 Billion of Roughly $25 Billion in Assets Already Relates to Prudential

by Team Lumida
1 day ago
Prudential Moves $5 Billion to Prismic, Where More Than $22 Billion of Roughly $25 Billion in Assets Already Relates to Prudential

The reinsurer has external investors including Warburg Pincus, but its book is overwhelmingly one client's risk.

Read more

Citi Cuts Its Analyst Programme to Two Years as Banks Compete on Tenure Because They Cannot Compete on Carry

by Team Lumida
1 day ago
Citi Cuts Its Analyst Programme to Two Years as Banks Compete on Tenure Because They Cannot Compete on Carry

Shortening promotion timelines moves an entire cohort onto associate pay a year earlier, permanently, to defend against a rival pay structure.

Read more
Next Post
NXP Semiconductors Guides for Further Revenue Decline as Q2 Profit Drops

NXP Semiconductors Guides for Further Revenue Decline as Q2 Profit Drops

Trump Threatens New Wave of Tariffs, Targeting Key Trading Partners with Rates Up to 40%

Trump’s Crackdown on Trade Loopholes Threatens 70% of China’s U.S. Exports, Risks Long-Term Growth

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

vitamin b 12 100 mg

AstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined RevenueAstraZenecaAstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined Revenue

August 3, 2026
Oil Prices Surge: What Falling US Crude Stocks Mean for Your Investments

US Temporarily Allows More Russian Oil Sales to Ease War-Driven Price Spike

March 13, 2026
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Trump’s Tariffs Face the Supreme Court: What’s at Stake

November 5, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018